UBS Group’s Mountain Crest Acquisition Corp. IV Common Stock MCAF Stock Holding History

UBS Group’s Portfolio MCAF Stock Details MCAF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-32	Closed	-$475	–	10460
2024 Q1	$475	Buy	+32	New	+$466	﹤0.01%	8533
2023 Q1	–	Sell	-1,770	Closed	-$17.8K	–	10838
2022 Q4	$17.8K	Sell	1,770 -734	-29%	-$7.33K	﹤0.01%	7793
2022 Q3	$25K	Sell	2,504 -659	-21%	-$6.52K	﹤0.01%	7119
2022 Q2	$31K	Buy	3,163 +1,732	+121%	+$17.1K	﹤0.01%	6374
2022 Q1	$14K	Buy	1,431 +433	+43%	+$4.28K	﹤0.01%	7980
2021 Q4	$10K	Buy	998 +393	+65%	+$3.86K	﹤0.01%	8815
2021 Q3	$6K	Buy	+605	New	+$5.9K	﹤0.01%	8468

UBS Group's MCAF Position: Q2 2024 in Review

UBS Group sold out of Mountain Crest Acquisition Corp. IV Common Stock (MCAF) in Q2 2024, closing a stake of 32 shares — an estimated $475 sold.

UBS Group first reported a position in MCAF in Q3 2021 and held it in 7 quarters. The position peaked at $31K in Q2 2022. 0 funds tracked by Wall St. Rank hold MCAF as of Q2 2024.

UBS Group reported no remaining Mountain Crest Acquisition Corp. IV Common Stock position as of Q2 2024 after selling out during the quarter.
UBS Group sold 32 Mountain Crest Acquisition Corp. IV Common Stock shares in Q2 2024, an estimated $475.
UBS Group first reported a position in Mountain Crest Acquisition Corp. IV Common Stock in Q3 2021 and held it in 7 quarters.
UBS Group's Mountain Crest Acquisition Corp. IV Common Stock position peaked at $31K in Q2 2022.
0 funds tracked by Wall St. Rank held Mountain Crest Acquisition Corp. IV Common Stock as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.